Tekla Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$6.38M Buy
336,200
+220,800
+191% +$4.19M 0.25% 76
2023
Q1
$1.79M Buy
+115,400
New +$1.79M 0.07% 124